- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/18 - Benzotriazoles
Patent holdings for IPC class C07D 249/18
Total number of patents in this class: 371
10-year publication summary
|
27
|
29
|
17
|
31
|
22
|
24
|
23
|
19
|
16
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 408 |
26 |
| Merck Patent GmbH | 5725 |
8 |
| Alcon, Inc. | 5816 |
7 |
| Vectus Biosystems Limited | 29 |
7 |
| Glaxosmithkline Intellectual Property Development Limited | 777 |
6 |
| Amgen Inc. | 4425 |
5 |
| Astex Therapeutics Limited | 208 |
5 |
| VALO Health, Inc. | 192 |
5 |
| NRG Therapeutics Ltd | 18 |
5 |
| Bayer Pharma AG | 1015 |
4 |
| Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. | 253 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
4 |
| Ecolab USA Inc. | 5795 |
4 |
| Miyoshi Oil & Fat Co., Ltd. | 107 |
4 |
| Theravance, Inc. | 61 |
4 |
| Trinapco, Inc. | 19 |
4 |
| Txinno Bioscience Inc. | 17 |
4 |
| Merck Sharp & Dohme LLC | 3728 |
4 |
| Novartis AG | 10300 |
3 |
| BASF SE | 21292 |
3 |
| Other owners | 255 |